Effective January 20, 2017, Rule 64B13-18.002, F.A.C. adds Xiidra (Lifitegrast Ophthalmic Solution) 5% to the formulary and allows Florida Optometrists to prescribe the medication to their patients.
More Latest News
October 16, 2017
Please Click for Details on the Urgent National Drug Shortage: Lidocaine with Epinephrine and Bupivacaine with Epinephrine Continue reading
September 13, 2017
Due to impacts from Hurricane Irma, Governor Scott has issued an executive order regarding the state of Florida Continue reading